SIC
GSK icon

SJS Investment Consulting’s GSK GSK Stock Holding History

SJS Investment Consulting’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.2K Buy
691
+483
+232% +$25.5K ﹤0.01% 582
2026
Q1 		$11.5K Hold
208
– – ﹤0.01% 804
2025
Q4 		$10.2K Buy
+208
New +$9.7K ﹤0.01% 780
2024
Q4 		– Sell
-316
Closed -$12.9K – 1646
2024
Q3 		$12.9K Buy
+316
New +$12.9K ﹤0.01% 341
2024
Q1 		– Sell
-100
Closed -$3.71K – 1667
2023
Q4 		$3.71K Buy
+100
New +$3.59K ﹤0.01% 457

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SJS Investment Consulting's GSK Position: Q2 2026 in Review

SJS Investment Consulting increased its GSK (GSK) stake by 232% in Q2 2026, buying an estimated $25.5K and bringing the position to 691 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

SJS Investment Consulting first reported a position in GSK in Q4 2023 and has held it in 5 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • SJS Investment Consulting held 691 shares of GSK worth $36.2K as of Q2 2026.
  • SJS Investment Consulting bought 483 GSK shares in Q2 2026, an estimated $25.5K.
  • GSK made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #582 holding.
  • SJS Investment Consulting first reported a position in GSK in Q4 2023 and has held it in 5 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.